Amid the ongoing uncertain market conditions, it could be wise to buy quality stocks, Bristol-Myers Squibb Company (BMY), Gilead Sciences, Inc. (GILD), and DoubleDown Interactive Co Ltd (DDI), trading at discounted valuations.
With the current regime of interest rate hikes already claiming numerous “growth” businesses and three of their financiers, until the time of writing this article, as unintended victims, market gains from asset price appreciation seem like a lost cause.
